Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Versus Double Suture Cervical Cerclage to Prevent Preterm Birth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04742647
Recruitment Status : Recruiting
First Posted : February 8, 2021
Last Update Posted : March 17, 2021
Sponsor:
Information provided by (Responsible Party):
Diana Garretto, Stony Brook University

Brief Summary:
Cerclage placement is known to be beneficial in prevention of preterm birth when placed inn a certain subset of patients. Clinically, the number of sutures can also vary by surgeon preference to one or two sutures in one procedure. This is often decided in the operating room (OR) on the day of surgery but is poorly studied in the efficacy of maintaining the closed cervical length. Retrospective data found no significant benefit on placing two stitches instead of one in preterm birth rate but was extremely limited and heterogenous in many clinical characteristic among the cerclage procedures. There were suggestions that two cerclage sutures may reduce the risk of cerclage revision, birth before 20 weeks, and a nonsignificant improvement in outcome of early preterm deliveries. Therefore, two randomized controlled trials, one prospective study and one meta-analysis were performed. They did suggest a beneficial effect of double cerclage on obstetrical outcomes especially in earlier preterm birth rates although all were limited in sample size and therefore power. A randomized control trial with adequate sample size is still needed to answer the question of whether double cervical cerclage suture is more beneficial than a single suture. Therefore, we propose conducting a randomized control trial between a single or double suture in prophylactic and ultrasound indicated cerclage procedures.

Condition or disease Intervention/treatment Phase
The Primary Outcome is Preterm Delivery Before 28 Weeks Gestational Age Compared to Women With One vs Two Cerclages Placed Procedure: Double cerclage Procedure: Single cerclage Not Applicable

Detailed Description:

Preterm birth (PTB), defined as birth at less than 37 completed weeks is the leading cause for neonatal mortality and morbidity in the USA. The most common risk factor for PTB is a prior preterm birth. The etiology includes several risk factors including prior preterm birth, cervical insufficiency, short cervical length, low socioeconomic and educational status, extremes of maternal age, genital tract infection/colonization, smoking, underlying chronic disease, uterine anomalies, cervical surgery, injury to the endometrium, race, and exposure to environmental factors. The objective of our study specifically focuses on cervical insufficiency and a short cervical length at <24 weeks gestation defined as less than 25 mm as measured by transvaginal ultrasonography. It is well known that infants born prematurely have increased morbidity and mortality, including respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, long term health and neurologic abnormalities, extensive hospital stays, neonatal death, etc. The risks are significantly more pronounced at earlier gestational ages. Cervical cerclage, when indicated, has been shown to be beneficial in reducing preterm birth rates and therefore decrease adverse neonatal outcomes, perinatal morbidity, and mortality. The indications for cervical cerclage include a history of recurrent second trimester losses and/or PTB (history indicated), short cervical length (<2.5cm on transvaginal ultrasound (ultrasound indicated), or a dilated cervix on physical exam (physical exam indicated). Our study focuses on history and ultrasound indicated cerclage.

There are various surgical approaches to placement of cervical cerclages- transvaginal and transabdominal. Our study focuses on the transvaginal approach and the modified McDonald technique with transvaginal placement of a purse-string suture at the cervicovaginal junction. Suture material varies by the surgeon's preference and can involve monofilament suture (Prolene), polyester fiber (Mersilene tape), or a braided polyester suture (Ti-Cron or Ethibond). Clinically, the number of sutures can also vary by surgeon preference to one or two sutures in one procedure. This is often decided in the operating room (OR) on the day of surgery but is poorly studied in the efficacy of maintaining the closed cervical length. Retrospective data found no significant benefit on placing two stitches instead of one in preterm birth rate but was extremely limited and heterogenous in many clinical characteristic among the cerclage procedures. There were suggestions that two cerclage sutures may reduce the risk of cerclage revision, birth before 20 weeks, and a nonsignificant improvement in outcome of early preterm deliveries. Therefore, two randomized controlled trials one prospective study and one meta-analysis were performed. They did suggest a beneficial effect of double cerclage on obstetrical outcomes especially in earlier preterm birth rates although all were limited in sample size and therefore power. A randomized control trial with adequate sample size is still needed to answer the question of whether double cervical cerclage suture is more beneficial than a single suture.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 84 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Single Versus Double Suture Cervical Cerclage to Prevent Preterm Birth: Prospective Randomized Controlled Trial
Actual Study Start Date : February 1, 2021
Estimated Primary Completion Date : July 1, 2023
Estimated Study Completion Date : July 1, 2023

Arm Intervention/treatment
Experimental: Single Cerclage
Standard single cervical cerclage will be placed
Procedure: Single cerclage
One cerclage will be placed

Experimental: Double Cerclage
Double cerclage placement
Procedure: Double cerclage
Two cervical cerlages will be placed




Primary Outcome Measures :
  1. Preterm delivery <28 weeks gestation [ Time Frame: through study completion, an average of 1 year ]
    Birth occurring less than 28 weeks and 0 days


Secondary Outcome Measures :
  1. Preterm delivery <34 weeks gestation [ Time Frame: through study completion, an average of 1 year ]
    Birth occurring less than 34 weeks and 0 days

  2. Preterm delivery <37 weeks gestation [ Time Frame: through study completion, an average of 1 year ]
    Births occurring less than 37 weeks and 0 days



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 years of age and older
  • Confirmed intrauterine, live pregnancy
  • Singleton gestation
  • Cerclage indications including:
  • Prophylactic due to history of cervical insufficiency, second trimester loss
  • Ultrasound indicated short cervix <25 mm prior to 24 weeks

Exclusion Criteria:

  • Rescue cerclage
  • Carrying a fetus with known aneuploidy or anomaly
  • Fetal demise
  • Clinical intra-amniotic infection
  • Rupture of membranes
  • Multiple gestation
  • Placental Abruption
  • Technique other than McDonald
  • Abdominal cerclage

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04742647


Locations
Layout table for location information
United States, New York
Stony Brook University Recruiting
Stony Brook, New York, United States, 11794
Contact: Deidre Lee    631-444-9324    deidre.lee@stonybrookmedicine.edu   
Principal Investigator: Diana Garretto, MD         
Sponsors and Collaborators
Stony Brook University
Layout table for additonal information
Responsible Party: Diana Garretto, MD Clinical Assistant Professor, Obstetric Quality Assurance Chair, Director Obstetric Ultrasound, Stony Brook University
ClinicalTrials.gov Identifier: NCT04742647    
Other Study ID Numbers: IRB2020-00731
First Posted: February 8, 2021    Key Record Dates
Last Update Posted: March 17, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications